• -
90 Results
Marijuana+Law
Marijuana Reform: Fears and Facts (Update)
With the Texas Legislature now considering several bills that would decrease penalties for marijuana possession and legalize the use of medical marijuana to treat a variety of conditions, authors William Martin and Katharine A. Neill present updated findings in this new issue brief that support the case for reforming marijuana policy in Texas.
Katharine Neill Harris, William Martin March 10, 2017
Person looking at graphs and charts
Science Advice in the Trump White House
As his term progresses, President Trump will be faced with a large number of policy challenges, some of them requiring immediate science & technology expertise. In this Science Magazine article, the authors urge the president to consider the Office of Science & Technology Policy, the science advisor and the presidential S&T councils as vital resources that should be used early in the term to drive his policy agenda.
Kirstin R.W. Matthews, Kenneth M. Evans, Neal F. Lane February 10, 2017
A woman receives a vaccine in her left arm.
How Too Much Freedom of Choice Endangers Public Health: The Effect of Nonmedical Exemptions From School-entry Vaccinations in Texas
This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.
Jackie Olive, Kirstin R.W. Matthews October 13, 2016
Pen pointing at chart
Drugs by the Numbers: The Brian C. Bennett Drug Charts
Using charts, figures and graphs of this survey data originally created by former career intelligence analyst Brian C. Bennett and updated by the Drug Policy Program, this issue brief offers an overview of drug use trends in America over the last four decades. The brief is part of a larger online project chronicling the pattern of the use and abuse of individual drugs over (in most cases) more than 40 years.
William Martin, Katharine Neill Harris August 1, 2016